Svein Øie

1.2k total citations
45 papers, 982 citations indexed

About

Svein Øie is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, Svein Øie has authored 45 papers receiving a total of 982 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 9 papers in Pediatrics, Perinatology and Child Health and 8 papers in Oncology. Recurrent topics in Svein Øie's work include Drug Transport and Resistance Mechanisms (8 papers), Neonatal Health and Biochemistry (5 papers) and Pharmacogenetics and Drug Metabolism (5 papers). Svein Øie is often cited by papers focused on Drug Transport and Resistance Mechanisms (8 papers), Neonatal Health and Biochemistry (5 papers) and Pharmacogenetics and Drug Metabolism (5 papers). Svein Øie collaborates with scholars based in United States, Germany and Taiwan. Svein Øie's co-authors include Thomas N. Tozer, Theodor W. Guentert, Peter W. Swaan, Francis C. Szoka, Gerhard Levy, Wolfgang Sadée, David C. Perry, Kary B. Mullis, Donghao Lu and Jin‐ding Huang and has published in prestigious journals such as Advanced Drug Delivery Reviews, Brain Research and International Journal of Pharmaceutics.

In The Last Decade

Svein Øie

44 papers receiving 928 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Svein Øie United States 16 368 306 240 149 145 45 982
Manabu Hanano Japan 22 446 1.2× 597 2.0× 292 1.2× 158 1.1× 251 1.7× 119 1.4k
David D. Christ United States 25 537 1.5× 335 1.1× 472 2.0× 177 1.2× 86 0.6× 49 1.9k
J H Lin United States 11 299 0.8× 344 1.1× 439 1.8× 153 1.0× 103 0.7× 13 1.1k
Per Garberg Sweden 14 411 1.1× 531 1.7× 203 0.8× 102 0.7× 213 1.5× 25 1.3k
Eric L. Reyner United States 15 419 1.1× 495 1.6× 177 0.7× 72 0.5× 177 1.2× 23 1.1k
George Tonn United States 17 332 0.9× 242 0.8× 256 1.1× 85 0.6× 73 0.5× 31 939
Dennis Dean United States 25 614 1.7× 381 1.2× 487 2.0× 171 1.1× 93 0.6× 66 2.0k
Andrea Soldner United States 9 178 0.5× 219 0.7× 200 0.8× 78 0.5× 119 0.8× 10 681
J.P. Tillement France 21 572 1.6× 327 1.1× 167 0.7× 247 1.7× 200 1.4× 66 1.4k
James G. Baxter United States 8 441 1.2× 385 1.3× 552 2.3× 155 1.0× 104 0.7× 10 1.3k

Countries citing papers authored by Svein Øie

Since Specialization
Citations

This map shows the geographic impact of Svein Øie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Svein Øie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Svein Øie more than expected).

Fields of papers citing papers by Svein Øie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Svein Øie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Svein Øie. The network helps show where Svein Øie may publish in the future.

Co-authorship network of co-authors of Svein Øie

This figure shows the co-authorship network connecting the top 25 collaborators of Svein Øie. A scholar is included among the top collaborators of Svein Øie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Svein Øie. Svein Øie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Øie, Svein. (2025). Concerns Regarding the Use of Kirchhoff’s Laws in Pharmacokinetics. AAPS PharmSciTech. 26(1). 30–30.
2.
Lu, Donghao & Svein Øie. (2004). Cellular drug delivery : principles and practice. Humana Press eBooks. 14 indexed citations
3.
Pan, Guangliang, Svein Øie, & Donghao Lu. (2004). Uptake of the Carborane Derivative of Cholesteryl Ester by Glioma Cancer Cells Is Mediated Through LDL Receptors. Pharmaceutical Research. 21(7). 1257–1262. 10 indexed citations
4.
Alanazi, Fars K., et al.. (2003). Synthesis, preformulation and liposomal formulation of cholesteryl carborane esters with various fatty chains. International Journal of Pharmaceutics. 255(1-2). 189–197. 16 indexed citations
5.
Pan, Guangliang, et al.. (2003). In vitro uptake of a new cholesteryl carborane ester compound by human glioma cell lines. Journal of Pharmaceutical Sciences. 93(1). 13–19. 13 indexed citations
6.
Greenspan, Phillip, et al.. (2002). VLDL‐resembling phospholipid‐submicron emulsion for cholesterol‐based drug targeting. Journal of Pharmaceutical Sciences. 91(6). 1405–1413. 19 indexed citations
7.
Hajda, Jacek, E. Jähnchen, Svein Øie, & Dietmar Trenk. (2002). Sequential First‐Pass Metabolism of Nortilidine: The Active Metabolite of the Synthetic Opioid Drug Tilidine. The Journal of Clinical Pharmacology. 42(11). 1257–1261. 13 indexed citations
8.
Swaan, Peter W., Francis C. Szoka, & Svein Øie. (1997). Molecular modeling of the intestinal bile acid carrier: a comparative molecular field analysis study.. Journal of Computer-Aided Molecular Design. 11(6). 581–588. 41 indexed citations
9.
Swaan, Peter W., C. T. Redemann, Mary X. Tang, et al.. (1997). Use of the Intestinal Bile Acid Transporter for the Uptake of Cholic Acid Conjugates with HIV-1 Protease Inhibitory Activity. Pharmaceutical Research. 14(2). 176–180. 37 indexed citations
10.
Swaan, Peter W., Francis C. Szoka, & Svein Øie. (1996). Use of the intestinal and hepatic bile acid transporters for drug delivery. Advanced Drug Delivery Reviews. 20(1). 59–82. 28 indexed citations
11.
Trenk, Dietmar, Bernhard R. Winkelmann, E. Jähnchen, & Svein Øie. (1988). Dose-dependent metabolism and hepatic distribution of phenprocoumon in rats. Journal of Pharmacokinetics and Biopharmaceutics. 16(1). 1–12. 1 indexed citations
12.
Huang, Jin‐ding & Svein Øie. (1985). Influence of serum protein binding on hepatic clearance of S-disopyramide in the rabbit. Journal of Pharmacy and Pharmacology. 37(7). 471–475. 10 indexed citations
13.
Øie, Svein. (1985). Pharmacokinetics of sulfisoxazole in rabbits with experimental renal failure after single and multiple dosing. International Journal of Pharmaceutics. 23(3). 345–355. 2 indexed citations
14.
Øie, Svein. (1983). Reviews: Pharmacokinetics, 2nd Ed.. Journal of Pharmaceutical Sciences. 72(11). 1370–1371. 1 indexed citations
15.
Øie, Svein, John G. Gambertoglio, & Lawrence Fleckenstein. (1982). Comparison of the disposition of total and unbound sulfisoxazole after single and multiple dosing. Journal of Pharmacokinetics and Biopharmaceutics. 10(2). 157–172. 13 indexed citations
16.
Øie, Svein & Jin‐ding Huang. (1981). Influence of Administration Route on Drug Delivery to a Target Organ. Journal of Pharmaceutical Sciences. 70(12). 1344–1347. 12 indexed citations
17.
Øie, Svein & Donald Jung. (1979). Bioavailability under Variable Renal Clearance Conditions. Journal of Pharmaceutical Sciences. 68(1). 128–129. 15 indexed citations
18.
Øie, Svein & Gerhard Levy. (1978). Frequency Distribution of Bilirubin Intrinsic Clearance in Adult Male Sprague–Dawley Rats. Journal of Pharmaceutical Sciences. 67(1). 45–47. 2 indexed citations
19.
Yacobi, Avraham, Svein Øie, & Gerhard Levy. (1977). Relationship between Protein Binding of Bilirubin, Salicylic Acid, and Sulfisoxazole in Serum of Unmedicated and Phenobarbital-Treated Rats. Journal of Pharmaceutical Sciences. 66(7). 1025–1027. 3 indexed citations
20.
Øie, Svein & Gerhard Levy. (1977). Interindividual differences in the effect of drugs on bilirubin plasma binding in newborn infants and in adults. Clinical Pharmacology & Therapeutics. 21(5). 627–632. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manabu Hanano Breakdown of academic impact, for papers by David D. Christ Breakdown of academic impact, for papers by J H Lin Breakdown of academic impact, for papers by Per Garberg Breakdown of academic impact, for papers by Eric L. Reyner Breakdown of academic impact, for papers by George Tonn Breakdown of academic impact, for papers by Dennis Dean Breakdown of academic impact, for papers by Andrea Soldner Breakdown of academic impact, for papers by J.P. Tillement Breakdown of academic impact, for papers by James G. Baxter
Rankless by CCL
2026